IL15 and neoplasm: Proceeding further on this line, another study by Yasuhiro Maruoka et al. [50] hypothesised that the administration of IL-15 with cancer cell-targeted NIR-PIT could also inhibit tumour growth by increasing anti-tumour host immunity.